Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07430254 · ClinicalTrials.gov registry record
Finger Plethysmography to Predict Fluid Responsiveness in Healthy Pregnancy and Severe Preeclampsia
A clinical trial, sponsored by Stanford University.
- Not yet
- Registry status
- 88
- Enrollment target
NCT07430254: Clinical Trial study, sponsored by Stanford University.
NCT07430254 is a clinical trial that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07430254 has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- 88 participants
- Enrollment target
Study Summary
The goal of this observational study is to determine whether noninvasive finger plethysmographic cardiac output monitoring can help predict fluid responsiveness in pregnant women, including those with preeclampsia with severe features. The main questions it aims to answer are : * Can changes in cardiac output measured by finger plethysmography predict fluid responsiveness? * How does this method perform compared with standard echocardiographic assessment? Participants will provide consent and undergo noninvasive hemodynamic monitoring and a brief reversible physiological challenge.
Interventions
- DIAGNOSTIC_TEST Noninvasive finger plethysmographic cardiac output monitoring
- DIAGNOSTIC_TEST Standard transthoracic echocardiographic assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07430254
The ClinicalTrials.gov registry entry for NCT07430254 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Noninvasive finger plethysmographic cardiac output monitoring is the first listed.
NCT07430254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07430254 about?
NCT07430254 is a clinical study titled "Finger Plethysmography to Predict Fluid Responsiveness in Healthy Pregnancy and Severe Preeclampsia". The goal of this observational study is to determine whether noninvasive finger plethysmographic cardiac output monitoring can help predict fluid responsiveness in pregnant women, including those with preeclampsia with severe features. The main questions it aims to answer are : * Can changes in ca...
What is the current status of trial NCT07430254?
This trial is currently not yet recruiting. The enrollment target is 88 participants. The study started on 2026-07-01. Estimated completion is 2028-07-01.
What interventions are being tested in trial NCT07430254?
The interventions under investigation include: Noninvasive finger plethysmographic cardiac output monitoring (DIAGNOSTIC_TEST), Standard transthoracic echocardiographic assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07430254?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.